Literature DB >> 19431079

Autoimmunity in autism.

Amanda M Enstrom1, Judy A Van de Water, Paul Ashwood.   

Abstract

Autism spectrum disorders is a heterogenous group of neurodevelopmental disorders, the etiology or etiologies of which remain unknown. Increasing evidence of autoimmune phenomena in individuals with autism could represent the presence of altered or inappropriate immune responses in this disorder, and this immune system dysfunction may represent novel targets for treatment. Furthermore, in recent studies, antibodies directed against the fetal brain have been detected in some mothers of children with autism; these antibodies have the ability to alter behavioral outcomes in the offspring of animal models. A better understanding of the involvement of the immune response in early brain development, with respect to autism, may have important therapeutic implications.

Entities:  

Mesh:

Year:  2009        PMID: 19431079      PMCID: PMC6952169     

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  118 in total

1.  Heat shock protein 90 antibodies in autism.

Authors:  M Evers; C Cunningham-Rundles; E Hollander
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

2.  Maternal antibrain antibodies in autism.

Authors:  Andrew W Zimmerman; Susan L Connors; Karla J Matteson; Li-Ching Lee; Harvey S Singer; Julian A Castaneda; David A Pearce
Journal:  Brain Behav Immun       Date:  2006-10-06       Impact factor: 7.217

3.  Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression.

Authors:  H Jyonouchi; S Sun; H Le
Journal:  J Neuroimmunol       Date:  2001-11-01       Impact factor: 3.478

4.  Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking.

Authors:  G Yovel; P Sirota; D Mazeh; G Shakhar; E Rosenne; S Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2000-09       Impact factor: 7.217

Review 5.  Novel treatments for autistic spectrum disorders.

Authors:  Susan E Levy; Susan L Hyman
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2005

6.  Detection of antinuclear and antilaminin antibodies in autistic children who received thimerosal-containing vaccines.

Authors:  Vijendra K Singh; Wyatt H Rivas
Journal:  J Biomed Sci       Date:  2004 Sep-Oct       Impact factor: 8.410

7.  Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring.

Authors:  Limin Shi; S Hossein Fatemi; Robert W Sidwell; Paul H Patterson
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

8.  High nitric oxide production in autistic disorder: a possible role for interferon-gamma.

Authors:  Thayne L Sweeten; David J Posey; Sudha Shankar; Christopher J McDougle
Journal:  Biol Psychiatry       Date:  2004-02-15       Impact factor: 13.382

9.  Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression.

Authors:  C Lintas; R Sacco; K Garbett; K Mirnics; R Militerni; C Bravaccio; P Curatolo; B Manzi; C Schneider; R Melmed; M Elia; T Pascucci; S Puglisi-Allegra; K-L Reichelt; A M Persico
Journal:  Mol Psychiatry       Date:  2008-03-04       Impact factor: 15.992

10.  Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.

Authors:  Latha Soorya; Jessica Kiarashi; Eric Hollander
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-10
View more
  42 in total

1.  Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.

Authors:  Gehan A Mostafa; Laila Y Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-04-25       Impact factor: 8.322

2.  Autism and urbanization.

Authors:  Kevin G Becker
Journal:  Am J Public Health       Date:  2010-05-13       Impact factor: 9.308

Review 3.  Improving the prediction of response to therapy in autism.

Authors:  Stephen Bent; Robert L Hendren
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 4.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

5.  Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder.

Authors:  I S Piras; L Haapanen; V Napolioni; R Sacco; J Van de Water; A M Persico
Journal:  Brain Behav Immun       Date:  2014-01-03       Impact factor: 7.217

6.  Breaking boundaries in neural-immune interactions.

Authors:  A Kimberley McAllister; Judy van de Water
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 7.  The role of immune dysfunction in the pathophysiology of autism.

Authors:  Charity Onore; Milo Careaga; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2011-08-28       Impact factor: 7.217

Review 8.  Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders.

Authors:  Young Shin Kim; Bennett L Leventhal
Journal:  Biol Psychiatry       Date:  2014-11-05       Impact factor: 13.382

9.  Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T + tf/J Mouse Model of Autism.

Authors:  Saleh A Bakheet; Mohammad Zeed Alzahrani; Mushtaq Ahmad Ansari; Ahmed Nadeem; Khairy M A Zoheir; Sabry M Attia; Laila Yousef Al-Ayadhi; Sheikh Fayaz Ahmad
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

10.  Defective oxytocin function: a clue to understanding the cause of autism?

Authors:  Fiorella Gurrieri; Giovanni Neri
Journal:  BMC Med       Date:  2009-10-22       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.